Devices and methods for pharmacokinetic-based cell culture system

Patent metadata

Field	Value
Publication number	US-9273276-B2
Application number	US-201113301261-A
Country	US
Kind code	B2
Filing date	Nov 21, 2011
Priority date	Apr 25, 2001
Publication date	Mar 1, 2016
Grant date	Mar 1, 2016

Abstract

A cell culture method using an in vitro microscale cell culture device having a first microscale chamber containing cells attached to an inner surface of the chamber and cell culture medium in contact with the cells. The cells are maintained in culture in the in vitro microscale cell culture device while flowing culture medium through the first chamber at a controlled rate to provide a liquid residence time value for the cells in the first chamber of the in vitro microscale cell culture device that is comparable to a liquid residence time value obtained with respect to comparable cells in vivo, such that metabolism by the cells in culture in the in vitro microscale cell culture device is comparable to metabolism by comparable cells in vivo.

First claim

What is claimed is:

1. A cell culture method, comprising:
providing an in vitro microscale cell culture device comprising a first microscale chamber of known dimensions having a known number of cells seeded onto an inner surface of the chamber and cell culture medium in contact with the cells, wherein the microscale cell culture device is configured for flow of culture medium through the first microscale chamber; and
maintaining the cells in culture in the in vitro microscale cell culture device while flowing the culture medium through the first chamber at a controlled rate that provides a liquid residence time value for the cells in the first chamber of the in vitro microscale cell culture device that is comparable to a liquid residence time value obtained with respect to comparable cells in vivo, such that metabolism by the cells in culture in the in vitro microscale cell culture device is comparable to metabolism by comparable cells in vivo.

2. The method of claim 1 , wherein the first chamber is a tube.

3. The method of claim 1 , wherein the microscale cell culture device comprises a plurality of microscale chambers containing cells attached to an inner surface of the chamber and cell culture medium in contact with the cells, wherein the microscale cell culture device is configured for flow of culture medium through the plurality of microscale chambers.

4. The method of claim 3 , wherein plurality of microscale chambers include chambers connected in series.

5. The method of claim 3 , wherein plurality of microscale chambers include chambers connected in parallel.

6. The method of claim 3 , wherein the cells in each of the plurality of microscale chambers are derived from a different organ.

7. The method of claim 1 , further comprising contacting the cells in the first microscale chamber with a test compound.

8. The method of claim 7 , further comprising evaluating the effect of the test compound on the cells.

9. The method of claim 7 , wherein the cells are hepatocytes and the method further comprises evaluating metabolism of the test compound by the cells.

10. The method of claim 7 , wherein the cells are hepatocytes and the method further comprises evaluating toxicity of the test compound toward the cells.

Assignees

• Shuler Michael
• Baxter Gregory T
• Sin Aaron
• Harrison Robert Andrew
• Meyers Scott
• Cornell Res Foundation Inc

Inventors

• Shuler Michael
• Baxter Gregory T
• Sin Aaron
• Harrison Robert Andrew
• Meyers Scott

Classifications

• G01N33/5067

  Liver cells · CPC title

• G01N33/5008

  for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics · CPC title

• C12M41/46 Primary

  of cellular or enzymatic activity or functionality, e.g. cell viability · CPC title

• C12N5/0671

  Three-dimensional culture, tissue culture or organ culture; Encapsulated cells · CPC title

• C12M41/48

  Automatic or computerized control (automatic analysis G01N35/00) · CPC title